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Abstract 
Background: Menorrhagia is the most common type of abnormal uterine bleeding, caused by disruption of 
hormonal regulation, uterine function or blood clotting. Developing an effective diagnostic strategy for menorrhagia 
will improve patient's quality of life and the disease management. Here we investigated the links between 
hematological characteristics and prolonged menstruation to determine the importance of the first line coagulation 
screening tests in young women .Materials and Methods: In a case-control design supervised by a specialist, 43 
menorrhagia cases and 104 age-matched controls were selected. Menstrual characteristics were evaluated by a 
standardized questionnaire distributed to high school and university young students. First line coagulation screening 
tests were performed for both groups and hematological indices were statistically assessed. Results: Statistical 
analysis showed that prolonged menstrual bleeding was significantly correlated to prolonged bleeding time (p 
value, 0.01) as well as  red blood cell count (p value, 0.04). The O blood group showed the greatest contribution 
to the bleeding periods longer than 7 days (53.4 %(. Additional coagulation tests revealed a patient with 
coagulation factor VII deficiency. Conclusion: The results of the present study revealed the importance of 
menorrhagia management in young women and showed a significant correlation between prolonged menstrual 
bleeding and blood types . Our study findings also suggest a significant association between prolonged 
menstruation and bleeding time test, emphasizing on the role of blood coagulation traits in susceptibility to 
menorrhagia. 
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Endometrial tissue undergoes rapid and serial 
changes during menstrual phases. This functional 
layer proliferates and differentiates in a steroid 
hormone-dependent manner(1). Shedding of the 
endometrium results in  menstrual flow consisting of 
blood, mucus and cellular debris (2).  
Menorrhagia also known as heavy menstrual 
bleeding (HMB) is defined as hemorrhage more than 
80 milliliters and/or longer than seven days per 
menstrual cycle. HMB is one of the most common 
complaints of women in reproductive age (1, 3). 
Excessive uterine bleeding can be caused by 
functional and hormonal defects such as uterine 
fibroids and ovarian cysts (4).  
Also, coagulation abnormalities account for 
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remarkable number of HMB cases. It has been shown 
that inherited deficiencies of coagulation factors are 
detectable in 10-15% of menorrhagia patients (5). 
Coagulation factors play pivotal role in clotting 
pathway, each responsible for a specific reaction. 
Inherited deficiency of the factors cause coagulation 
disorders including hemophilia and von Willebrand 
disease (VWD) (6).  
First line coagulation screening tests include 
prothrombin time (PT), partial thromboplastin time 
(PTT), bleeding time (BT), and platelet count (Plat) 
which are frequently used in HMB evaluation. PT 
determines the blood clotting tendency and 
coagulation extrinsic pathway status by analysis of 
factors I (fibrinogen), II (prothrombin), V, VII, and 
X, while PTT represents the intrinsic and common 
pathway functions. BT verifies the vessel 
constriction and plug formation and could be affected 
by certain vascular disorders, platelet abnormalities 
and VWD (7).  
It should be noted that some of the coagulation 
diseases occur in mild forms, which increase the 
susceptibility to HMB. However, these patients are 
not generally under proper medical care. Genetic 
variants including single nucleotide polymorphisms 
(SNP's) should also be borne in mind which make the 
patient susceptible to HMB without fully manifesting 
the disease. Given this evidence, in addition to 
diagnosed coagulopathy patients, other women who 
are suffering from heavy bleeding should be screened 
(8). Since many of these predisposed young women 
do not seek medical treatment, community-based 
screening can be an advantage over screening for 
those referring to medical centers.  
Considering the high impact of menorrhagia 
on patients educational, social and psychological 
conditions and consequently the quality of life, we 
designed this study to achieve a low cost and 
effective strategy for HMB screening. We 
particularly aimed to investigate the correlation 
between prolonged menstrual bleeding (PMB) and 
first line coagulation screening tests.  
Methods 
Participants. Participants were identified 
based on the data collected via more than 700 
questionnaires distributed to high school and 
university female students. The questionnaire 
contained general health records of their medical 
history as well as menstrual bleeding status. They 
were asked to record the bleeding duration and 
symptoms of menstrual periods in a row. Reviewing 
the questionnaires and volunteers' interview revealed 
that 98% of the contents reflected in the questionnaire 
were accurate and reliable.  
A case-control study comprising PMB and non-
PMB groups was designed to determine  correlation 
between extended bleeding and hematological traits 
variations.  
From the respondents to questionnaires, a group 
of 43 PMB cases and a control group comprising 104 
non-PMB age-matched women were selected. Patients 
with a definitive diagnosis of HMB such as uterine 
fibroids and ovarian cysts were excluded from the 
study. 
The participants contributed to this study, on a 
volunteer basis and signed a written informed consent 
approved by the ethics committee of Iran University of 
Medical Sciences, Tehran, Iran. 
Hematological assessments. The patients and 
normal individuals were referred to Comprehensive 
Hemophilia Care Center Tehran, Iran for blood tests. 
In the first step, the complete blood count (CBC) was 
assessed which routinely included the following: white 
blood cell count (WBC), red blood cell count (RBC), 
red cell distribution width (RDW), Hb (hemoglobin), 
hematocrit (Hct), mean corpuscular volume (MCV), 
mean corpuscular hemoglobin (MCH), mean 
corpuscular hemoglobin concentration (MCHC) and 
Plat. Supplemental blood types test and RH were also 
performed. 
First line coagulation screening tests included 
BT, PT, PTT were analyzed by the same laboratory 
technician and setup. Complementary tests including 
coagulation factor antigens were performed in cases 
where first line coagulation screening suspected of a 
kind of coagulopathy.  
Statistical analysis. The collected data were 
statistically analyzed using SPSS version 16. 
Correlation studies of the quantitative and qualitative 
data were performed by ANOVA and chi-square tests, 
respectively. T-test was used to compare differences 
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between two independent parameters that normally 
distributed and the Mann-Whitney U test was applied 
to not normally distributed data. The p value <0.05 
was considered statistically significant. 
Results 
Menstrual characteristics. According to the 
data obtained from the cases’ questionnaires, mean
age was 19.96 year with a standard deviation of 2.18 
while the controls mean age was 18.12 ±3.05.  
At initial interview, 88.3% of cases and 81.9% 
of controls experienced menarche longer than 3 
years. Seventy-eight percent of cases and 75% of 
controls reported spectra of dysmenorrhea which 
could be considered as the hypothalamic–pituitary–
gonadal axis development. Along with 
dysmenorrhea, premenstrual symptoms are other 
common signs of ovulatory cycle's occurrence. Thus, 
questions were posed in the case of symptoms such 
as headache, irritability, gastrointestinal symptoms 
and etc. Forty-two percent of the cases reported that 
they always experience these symptoms, whereas, 
28% of them had the symptoms occasionally. These 
values for the controls were 63% and 22%, 
respectively. Statistical analysis showed no 
significant difference in prevalence of non- ovulatory 
cycles between the two groups.  
Hematological assessments: Anemia. PMB 
and non-PMB groups were evaluated for the 
correlation between menstruation longer than seven 
days and hematological indices.  ANOVA test 
showed that there was a significant association 
between PMB and RBC (p value, 0.04). The mean 
values of indices in two groups are indicated in 
Table-1. As shown, the significant association was 
only observed for RBC but not for the other 
parameters emphasizing a weak association between 
prolonged menstruations and developing anemia. 
Since Iron therapy affect anemia, the analyses were 
weighted for this confounding factor in the exact 
logistic model.  However, the results remained 
unchanged, suggesting that our analysis was not 
markedly affected by Iron supplements. Previous 
reports have shown a link between PMB and anemia, 
however, our study did not reach significant results 
in this regards. This discrepancy can stem from the 
prevalence of anemia in the healthy group due to 
nutritional causes.  














RBC(106/µl) 4.7±.3 5.12±.6 .040 4.7-4.9 
Hb(g/dl) 12.61±1.3 13.1±1.0 .289 12.7-13.3
Hct(%) 40.71±2.0 40.89±2.2 .268 39.7-41.0
MCV(fl) 85.91±4.4 84.99±3.7 .191 81.7-84.4
MCH(pg/cell) 27.82±2.1 27.37±2.4 .430 25.9-27.4
MCHC(g/dl) 32.36±1.6 32.39±1.4 .553 31.7-32.6 
RDW (%) 12.38 12.50 .345 12.6-13.2
Plat(x1000) 278±73 258±48 .126 248-281 
RBC; Red Blood Cell count, Hb; hemoglobin, Hct; hematocrit, MCV; 
Mean Corpuscular Volume , MCH; Mean Corpuscular Hemoglobin, 
MCHC; Mean Corpuscular Hemoglobin Concentration,  RDW; Red 
cell distribution Width, Plat; Platelets
Hematological assessments: Blood Types. 
Statistical analysis showed interesting results 
regarding blood groups. By comparing the two groups, 
we observed a significant correlation between PMB 
and blood types (p value, 0.008 and χ2, 20.64). Data 
analysis showed that 53.4% of PMB cases had O 
blood type vs. 33.6% of control group. Regarding 
blood types A and AB the differences were not 
significant as they were almost equal in both groups. 
Blood type B was detected in 21.1% of controls, but 
there was only one B blood type case in PMB group 
(2.4%). Figure 1 shows the distribution of blood types 
in both groups. It should be noted that our results 
revealed no link between prolonged menstruation and 
RH. 
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Figure 1 – The percentage of the blood types in control (Up) 
and case (Down) groups.  
 
Hematological assessments: coagulopathies. 
A significant correlation was observed between PMB 
and BT testing results (p value, 0.018). However the 
differences between Plat, PT and PTT in two groups 
were not statistically significant (Table-1 and Table-
2). 
 
Table 2- The mean values of First line coagulation screening 
tests in case and control groups 
 
BT; Bleeding Time, PT; Prothrombin Time, PTT; Partial Thrombin 
Time 
 
The results of first line coagulation screening 
tests revealed that six out of 43 cases were suspected 
of having some type of coagulation disorder. 
Complementary tests confirmed the presence of FVII 
deficiency in one patient but not a pathogenic 
condition in the remaining patients. However, the 
specialist suggested further follow-up over a longer 
period for other five cases. The FVII deficiency 
patient suffered from menorrhagia, chronic nosebleeds 





Abnormal uterine bleeding is partly caused by 
hormonal dysfunction and uterine disorders; however, 
there are still other cases due to various underlying 
diseases that need to be identified.  At puberty, 
menstrual cycles without ovulation are common in the 
first three years which root in the lack of 
hypothalamic-pituitary axis development and impaired 
ovarian LH secretion (9). These periods are associated 
with adequate levels of LH and FSH required for 
ovulation induction and secretion of estrogen, but not 
enough for oocyte maturation and ovulation (4). In our 
study, given the reported symptoms and clinical 
examination, anovulatory cycles were observed in less 
than 10% of the subjects. A retrospective study on the 
patients attended the adolescent gynecology clinic 
revealed hypothalamic-pituitary-ovarian axis 
immaturity in 28 out of 73 patients following a 
negative bleeding disorder screening (10).  
The second most common cause of HMB in 
adolescents is hereditary or acquired coagulation 
disorder (11). Retrospective studies showed the 
prevalence of menorrhagia in 10-62% of adolescents 
compared to 20% in older females (12). On the other 
side, the menorrhagia due to bleeding disorder was 
reported in most of the patients (13). Considerable 
evidence indicate that 5-36% of adolescents with 
HMB suffer from VWD, 2-44% from platelet function 
defects, 13-20% from thrombocytopenia, and 8-9% 
from clotting factor deficiencies that implies a 
dispersed distribution in populations (14).  
Owing this fact, first line coagulation screening 
tests are recommended for the detection of inherited 
bleeding disorders or predisposed people. Abnormal 
test results may direct physicians to the assessment of 













3.3-3.6 .018 3.27±.4 3.88±.7 BT 
10-10.1 .696 10.05±.1 10.13±.3 PT 
31.8-33.1 .082 33.4±2.5 32±2 PTT 
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showed a significant association with BT test. As it 
was mentioned earlier, BT is influenced by 
thrombocytopenia, platelet disorders and VWD (16).  
Type 1 VWD is the most common type of the disease 
with mild symptoms or asymptomatic phenotype. In 
addition, females with heterozygous type 2 or type 3 
VWD are either clinically asymptomatic or may 
present only mild bleeding tendency (17). The 
clinical diagnosis of such cases is a complex issue, as 
the variations in VWF levels possibly lead to 
prolonged bleeding time with mild hematological 
index changes (18). A recent cohort study reported a 
newly diagnosed type 2A VWD patient among 40 
adolescents with PMB upon their initial presentation 
to the hospital. In the rest of the subjects coagulation 
assay results were in the normal ranges (19). By 
studying 120 Irish women with low VWF levels, 
Lavin et al showed HMB in 89% of the cases. They 
reported that 89.2% of low VWF cases had blood 
group O vs. 55% of the general population (20). 
In this regard, the other finding by our study 
revealed a correlation between blood types and 
menorrhagia.  
The bleeding tendency in various diseases can 
be directly affected by blood groups. Previous studies 
in duodenal ulcers bleeding and post‐tonsillectomy 
hemorrhage showed that individuals with O blood 
group were at higher risk. Researchers attribute this 
effect to the blood groups links with the VWF (21). 
An important regulator of VWF levels in blood are 
blood group antigens. It has been previously shown 
that VWD and the Factor 8 display decreased level of 
25-30% in individuals with blood type O (22). ABH 
antigenic determinants have been localized on the N-
linked oligosaccharide chains of plasma VWF. ABO 
group affects VWF plasma clearance rates as the 
half-life of the protein in O blood type is 40% of the 
individuals with other blood types (23). The impact 
of blood groups on the VWF plasma levels also 
makes it difficult to diagnose type 1 VWD since the 
normal range of VWF antigen in individuals with O 
blood group is lower than conventional normal 
values (24). However, in a study of more than 4,000 
samples, no association was found between O blood 
type and early postpartum hemorrhage (PPH)(25). It 
can be concluded that the influence of blood group 
on adolescent menorrhagia is more specific and can 
be considered as an evaluation indicator. 
The number of adolescents admitted to 
hospitals due to severe menstrual bleeding is 
significant. To date an agreed approach is not applied 
and since HMB profoundly affects the patients’ health, 
it is necessary to formulate a guideline for early 
identification of patients at high risk (26). 
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